These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 22428836)

  • 1. Committeeville and drug users as social change agents.
    Ryan J
    Subst Use Misuse; 2012 Apr; 47(5):601-4. PubMed ID: 22428836
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug users as social change agents: increasing but limited possibilities in Sweden.
    Storbjörk J
    Subst Use Misuse; 2012 Apr; 47(5):606-9. PubMed ID: 22428838
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug users as social change agents in Asia: the diversity of experience and challenges.
    Sharma M; Chatterjee A
    Subst Use Misuse; 2012 Apr; 47(5):604-6. PubMed ID: 22428837
    [No Abstract]   [Full Text] [Related]  

  • 4. Active drug users as social change agents: some ethical dimensions.
    Kleinig J
    Subst Use Misuse; 2012 Apr; 47(5):596-8. PubMed ID: 22428833
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug users as social change agents: example of Austria.
    Edelbacher M
    Subst Use Misuse; 2012 Apr; 47(5):592-3. PubMed ID: 22428831
    [No Abstract]   [Full Text] [Related]  

  • 6. Views: Active drug users as social change agents a straw for the pilgrim: beyond specialization.
    Allamani A
    Subst Use Misuse; 2012 Apr; 47(5):588-90. PubMed ID: 22428829
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug user organizations in the Nordic countries--local, national, and international dimensions.
    Frank VA; Anker J; Tammi T
    Subst Use Misuse; 2012 Apr; 47(5):462-73. PubMed ID: 22428815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partnerships and communities in English drug policy: the challenge of deprivation.
    Macgregor S; Thickett A
    Int J Drug Policy; 2011 Nov; 22(6):478-90. PubMed ID: 21890338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The scalpel & the sword. A policymaker's journey in health advocacy.
    Coye MJ
    Health PAC Bull; 1988; 18(4):9-14. PubMed ID: 10291790
    [No Abstract]   [Full Text] [Related]  

  • 10. Maybe not perfect-but surely good enough?
    van Beek I
    Int J Drug Policy; 2012 Mar; 23(2):108. PubMed ID: 22088911
    [No Abstract]   [Full Text] [Related]  

  • 11. A special advocacy challenge--being effective in the health policy arena.
    Gomez EG
    Clin J Oncol Nurs; 2003; 7(2 Suppl):36-40. PubMed ID: 12703098
    [No Abstract]   [Full Text] [Related]  

  • 12. Advocacy reconsidered: progress and prospects.
    Levey S; Hill J
    Hosp Health Serv Adm; 1988; 33(4):467-79. PubMed ID: 10290100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modernizing medicine: demonstrating a policy of prevention.
    Ratzan SC
    J Health Commun; 2004; 9(2):89-90. PubMed ID: 15204819
    [No Abstract]   [Full Text] [Related]  

  • 14. Adapt to change or resist it? Or master change and steer it in the direction you want!
    Leblanc L
    Perspect Infirm; 2006; 3(5 Suppl):6. PubMed ID: 16776036
    [No Abstract]   [Full Text] [Related]  

  • 15. [Society and science: choices and stakes].
    McTeer M
    Infirm Que; 2001; 8(4):36-7. PubMed ID: 11887686
    [No Abstract]   [Full Text] [Related]  

  • 16. Nurses need more education in healthcare policy making.
    Allen LK
    Oncol Nurs Forum; 2003; 30(3):357-8. PubMed ID: 12725229
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient power: complex issues need complex answers.
    Wiener C; Fagerhaugh S; Strauss A; Suczek B
    Soc Policy; 1980; 11(2):30-8. PubMed ID: 10248425
    [No Abstract]   [Full Text] [Related]  

  • 18. Making health care better.
    Blando P
    Healthplan; 1998; 39(3):21-6. PubMed ID: 10181748
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of healthy public policy: feminist analysis of conflict, collaboration and social change.
    Scott CM; Thurston WE; Crow B
    Health Care Women Int; 2002; 23(6-7):530-9. PubMed ID: 12418975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the 'patient protection' debate. Interview by Diana Madden.
    Ignagni K
    Healthplan; 1999; 40(5):34-7, 40, 42. PubMed ID: 10622966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.